121 related articles for article (PubMed ID: 1480772)
1. Time factors in breast carcinoma: influence of delay between external irradiation and brachytherapy.
Dubray B; Mazeron JJ; Simon JM; Thames HD; Le Péchoux C; Calitchi E; Otmezguine Y; Le Bourgeois JP; Pierquin B
Radiother Oncol; 1992 Dec; 25(4):267-72. PubMed ID: 1480772
[TBL] [Abstract][Full Text] [Related]
2. Influence of dose rate on local control of breast carcinoma treated by external beam irradiation plus iridium 192 implant.
Mazeron JJ; Simon JM; Crook J; Calitchi E; Otmezguine Y; Le Bourgeois JP; Pierquin B
Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1173-7. PubMed ID: 1938515
[TBL] [Abstract][Full Text] [Related]
3. [Place of iridium 192 implantation in irradiation of T1-T2 squamous cell carcinoma of the velopharyngeal arch].
Mazeron JJ; Belkacemi Y; Simon JM; Le Péchoux C; Martin M; Haddad E; Piedbois P; Calitchi E; Strunski W; Peynègre R; Le Bourgeois JP; Pierquin B
Bull Cancer Radiother; 1996; 83(1):47-53. PubMed ID: 8679281
[TBL] [Abstract][Full Text] [Related]
4. Place of Iridium 192 implantation in definitive irradiation of faucial arch squamous cell carcinomas.
Mazeron JJ; Belkacemi Y; Simon JM; Le Pechoux C; Martin M; Haddad E; Piedbois P; Calitchi E; Strunski W; Peynegre R
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):251-7. PubMed ID: 8407398
[TBL] [Abstract][Full Text] [Related]
5. Iridium-192 versus cobalt-60 boost in 3-7 cm breast cancer treated by irradiation alone: final results of a randomized trial.
Fourquet A; Campana F; Mosseri V; Cetingoz R; Luciani S; Labib A; Asselain B; Vilcoq JR
Radiother Oncol; 1995 Feb; 34(2):114-20. PubMed ID: 7597209
[TBL] [Abstract][Full Text] [Related]
6. Treatment duration as a prognostic factor for local control and survival in epidermoid carcinomas of the tonsillar region treated by combined external beam irradiation and brachytherapy.
Hoffstetter S; Marchal C; Peiffert D; Luporsi E; Lapeyre M; Pernot M; Bey P
Radiother Oncol; 1997 Nov; 45(2):141-8. PubMed ID: 9424004
[TBL] [Abstract][Full Text] [Related]
7. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant.
Lawenda BD; Taghian AG; Kachnic LA; Hamdi H; Smith BL; Gadd MA; Mauceri T; Powell SN
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):671-80. PubMed ID: 12788172
[TBL] [Abstract][Full Text] [Related]
8. External beam irradiation plus (192)Ir implant after breast-preserving surgery in women with early breast cancer.
Moreno F; Guedea F; Lopez Y; Ferrer F; Gutierrez C; Petriz L; Pera J
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):757-65. PubMed ID: 11020573
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of treatment for prostate carcinoma by staging pelvic lymph node dissection and definitive irradiation using low-dose rate temporary iridium-192 interstitial implant and external beam radiotherapy.
Puthawala AA; Syed AM; Austin PA; Cherlow JM; Perley JM; Shanberg AM; Sawyer DE; Ingram JE; Baghdassarian R; Wachs BH; Perley JE; Londrc A; Espinoza-Ferrel T
Cancer; 2001 Oct; 92(8):2084-94. PubMed ID: 11596024
[TBL] [Abstract][Full Text] [Related]
10. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: a nonrandomized comparison.
Perez CA; Taylor ME; Halverson K; Garcia D; Kuske RR; Lockett MA
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):995-1007. PubMed ID: 8600112
[TBL] [Abstract][Full Text] [Related]
11. Early breast cancer: influence of type of boost (electrons vs iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy.
Touboul E; Belkacemi Y; Lefranc JP; Uzan S; Ozsahin M; Korbas D; Buffat L; Balosso J; Pene F; Blondon J
Radiother Oncol; 1995 Feb; 34(2):105-13. PubMed ID: 7597208
[TBL] [Abstract][Full Text] [Related]
12. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
Momma T; Saito S; Toya K; Yorozu A; Dokiya T; Murai M
Int J Urol; 2006 Mar; 13(3):218-23. PubMed ID: 16643612
[TBL] [Abstract][Full Text] [Related]
13. Influence of dose-rate and dose per fraction on clinical outcome of breast cancer treated by external beam irradiation plus iridium-192 implants: analysis of 289 cases.
Deore SM; Sarin R; Dinshaw KA; Shrivastava SK
Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):601-6. PubMed ID: 8330988
[TBL] [Abstract][Full Text] [Related]
14. Interstitial iridium-192 implantation combined with external radiotherapy in anal cancer: ten years experience.
Sandhu AP; Symonds RP; Robertson AG; Reed NS; McNee SG; Paul J
Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):575-81. PubMed ID: 9486607
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a phase I/II clinical trial.
Stromberg J; Martinez A; Gonzalez J; Edmundson G; Ohanian N; Vicini F; Hollander J; Gustafson G; Spencer W; Yan Di
Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):161-71. PubMed ID: 7543891
[TBL] [Abstract][Full Text] [Related]
16. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
17. Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation.
Stromberg J; Martinez A; Benson R; Garton G; Diokno A; Gonzalez J; Zincke H; Schray M; Edmundson G; Brabbins D
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):67-75. PubMed ID: 8270460
[TBL] [Abstract][Full Text] [Related]
18. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma.
Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; O SK
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):405-12. PubMed ID: 10802367
[TBL] [Abstract][Full Text] [Related]
19. Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies.
Gupta AK; Vicini FA; Frazier AJ; Barth-Jones DC; Edmundson GK; Mele E; Gustafson GS; Martinez AA
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1055-60. PubMed ID: 10192355
[TBL] [Abstract][Full Text] [Related]
20. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
